FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Baricitinib 4 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Baricitinib 4 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Calcium carbonate 900 mg/g cutaneous powder Count of base of active ingredient False un Inferred relationship Some
Calcium carbonate 900 mg/g cutaneous powder Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing only calcium carbonate in cutaneous dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Pilocarpine nitrate 20 mg/mL eye drops solution Count of base of active ingredient False un Inferred relationship Some
Pilocarpine nitrate 20 mg/mL eye drops solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Dihydrocodeine tartrate 2.42 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Dihydrocodeine tartrate 2.42 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Hydroxocobalamin (as hydroxocobalamin chloride) 1 mg/mL solution for injection Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely calcium acetate 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely calcium acetate 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Bilastine 20 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Bilastine 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing only bilastine in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Bazedoxifene (as bazedoxifene acetate) 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely azilsartan medoxomil (as azilsartan medoxomil potassium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing only bazedoxifene in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Bazedoxifene only product Count of base of active ingredient False un Inferred relationship Some
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Benzyl benzoate 250 mg/mL cutaneous emulsion Count of base of active ingredient False un Inferred relationship Some
Benzyl benzoate 250 mg/mL cutaneous emulsion Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely tocilizumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Mifepristone 600 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Mifepristone 600 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely levocarnitine 300 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Niacin 500 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
Niacin 500 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Atropine sulfate 200 microgram/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
Atropine sulfate 200 microgram/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely misoprostol 400 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely misoprostol 400 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely epinephrine 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely epinephrine 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Clotrimazole 200 mg vaginal pessary Count of base of active ingredient False un Inferred relationship Some
Clotrimazole 200 mg vaginal pessary Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal pessary (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely clotrimazole 500 milligram/1 each conventional release vaginal pessary (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Desmopressin acetate 100 microgram/mL nasal drops solution Count of base of active ingredient False un Inferred relationship Some
Desmopressin acetate 100 microgram/mL nasal drops solution Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Miconazole 20 mg/g oral gel Count of base of active ingredient False un Inferred relationship Some
Miconazole 20 mg/g oral gel Has concentration strength denominator value False un Inferred relationship Some 1
Calcium undecylenate 100 mg/g cutaneous powder Count of base of active ingredient False un Inferred relationship Some
Calcium undecylenate 100 mg/g cutaneous powder Has concentration strength denominator value False un Inferred relationship Some 1
Propamidine isethionate 1 mg/mL eye drops solution Count of base of active ingredient False un Inferred relationship Some
Propamidine isethionate 1 mg/mL eye drops solution Has concentration strength denominator value False un Inferred relationship Some 1
Propamidine isethionate 1 mg/mL eye drops solution Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Wool alcohol 2 mg/g eye ointment Count of base of active ingredient False un Inferred relationship Some
Wool alcohol 2 mg/g eye ointment Has concentration strength denominator value False un Inferred relationship Some 1
Wool alcohol only product in ocular dose form Count of base of active ingredient False un Inferred relationship Some
Acetylcysteine 600 mg effervescent oral tablet Count of base of active ingredient False un Inferred relationship Some
Acetylcysteine 600 mg effervescent oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Soybean oil refined 200 mg/mL emulsion for infusion Count of base of active ingredient False un Inferred relationship Some
Soybean oil refined 200 mg/mL emulsion for infusion Has concentration strength denominator value False un Inferred relationship Some 1
Soybean oil refined 100 mg/mL emulsion for infusion Count of base of active ingredient False un Inferred relationship Some
Soybean oil refined 100 mg/mL emulsion for infusion Has concentration strength denominator value False un Inferred relationship Some 1
Soybean oil only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
Product containing only carbon dioxide (medicinal product) Count of base of active ingredient False un Inferred relationship Some
Product containing only carbon dioxide in conventional release gas for inhalation (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Helium only product in gas for inhalation Count of base of active ingredient False un Inferred relationship Some
oxygène Count of base of active ingredient False un Inferred relationship Some
Vinflunine only product Count of base of active ingredient False un Inferred relationship Some
Vinflunine only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
Alectinib (as alectinib hydrochloride) 150 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
Alectinib (as alectinib hydrochloride) 150 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
Product containing only vandetanib in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely vandetanib 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely vandetanib 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Vandetanib 300 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
Vandetanib 300 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing only valrubicin in intravesical dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing only nelarabine in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
Brentuximab vedotin only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some

Start Previous Page 111 of 217 Next End


This concept is not in any reference sets

Back to Start